Bosutinib 380843-75-4: Effective Treatment for Chronic Myeloid Leukemia
Click to enlarge

Bosutinib 380843-75-4: Effective Treatment for Chronic Myeloid Leukemia

China BeijingBeijing Sjar Technology Development Co., Ltd.

US$-1.00

MOQ1 g

Product profile

Appearance
Pale Yellow to Yellow Powder
Purity
More Than 99%

Company profile

Beijing Sjar Technology Development Co., Ltd.

北京时嘉科技发展有限公司
China BeijingFloor 8, Building 1, No. 35, Jinghai Four Road, Economic and Echnological Development Zone, Beijing, China
  • CertifiedVerified Supplier
  • Business Type: Combined
  • Established: 2014
  • Employees: 31
  • Plant Area: 4260.0m²
  • Avg. Response Time: ≤ 7.81h
  • Certification: ISO9001:2015 certificate,ISO45001:2018 certificate,ISO14001
  • System Certification: ISO9001:2015 certificate,ISO14001:2015 certificate

Main Products

  • Pharmaceutical Chemicals
  • Electronic Chemicals
  • Apis
  • OLED Chemicals
  • OLED Intermediates
  • Opv Chemicals
  • Opv Intermediates
  • Pharmaceutical Intermediates

Main Markets

South America,Southeast Asia/ Mideast,East Asia(Japan/ South Korea),Europe,North America